Amedisys says its second-quarter earnings will be down from its original projections, partially due to SEC and U.S. Senate investigations into Medicare reimbursements. The company is now forecasting e…
Already an INSIDER? Sign in.
We are glad you enjoy reading Business Report.
Continue reading this story and get ACCESS to all our content from any device with a subscription now.
- Get access to more than a decade of story archives.
- Get access to our searchable data center of TOP LISTS.
- Get exclusive content only available to INSIDERS.